Steroid drug dexamethasone may be key in helping to treat the sickest Covid-19 patients.
According to researchers in the United Kingdom, findings are preliminary, still being compiled and have not been published in a peer-reviewed journal — but some not involved with the study called the results a breakthrough.
“This is a completely compelling result. If one looks at the patients who did not require ventilators but were on oxygen, there was also a significant risk reduction of about one-fifth,” Martin Landray, deputy chief investigator of the trial and a professor at the University of Oxford, said on Tuesday.
“However, we didn’t see any benefit in those patients who were in hospital, had Covid, but whose lungs were working sufficiently well — they were not taking either oxygen or on ventilators.”
As CNN reports, Landray added that “there are outstanding questions” and people treating Covid-19 at home should not be taking dexamethasone on the back of these results.